ALTAREX MEDICAL CORP.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ALTAREX MEDICAL CORP..The latest application filed is for "binding agents and their use in targeting tumor cells".

Company Profile

0.4.9

ALTAREX MEDICAL CORP. - EDMONTON CA
AltaRex Medical Corp. -
AltaRex Medical Corp. - Alberta CA
AltaRex Medical Corp. - 1123 Dentistry/Pharmacy Building University of A Edmonton AB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Binding Agents And Their Use In Targeting Tumor Cells App 20090291075 - Eng; Hubert ; et al.	2009-11-26
Reagents and methods for inducing an immune response to prostate specific antigen App 20090220493 - Leveugle; Beatrice ; et al.	2009-09-03
Reagents and methods for inducing an immune response to prostate specific antigen Grant 7,579,445 - Leveugle , et al. August 25, 2	2009-08-25
Method for diagnosing efficacy of xenotypic antibody therapy App 20090202560 - Madiyalakan; Ragupathy ; et al.	2009-08-13
Combination therapy for treating disease App 20080311127 - Schultes; Birgit C. ; et al.	2008-12-18
Method and composition for reconforming multi-epitopic antigens to intiate an immune response App 20080131443 - Madiyalakan; Ragupathy ; et al.	2008-06-05
Therapeutic compositions that alter the immune response Grant 7,318,921 - Madiyalakan , et al. January 15, 2	2008-01-15
Method and composition for reconforming multi-epitopic antigens to initiate an immune response App 20070092522 - Noujaim; Antoine A.	2007-04-26
Method and composition for reconforming multi-epitopic antigens to initiate an immune response App 20070036798 - Madiyalakan; Ragupathy ; et al.	2007-02-15
Therapeutic binding agents against MUC-1 antigen and methods for their use Grant 7,147,850 - Madiyalakan December 12, 2	2006-12-12
Binding agents and their use in targeting tumor cells App 20050260208 - Eng, Hubert ; et al.	2005-11-24
Reagents and methods for inducing an immune response to prostate specific antigen Grant 6,881,405 - Leveugle , et al. April 19, 2	2005-04-19
Combination therapy for treating disease App 20050063976 - Schultes, Birgit C. ; et al.	2005-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.